Why I Work at Acuitas – A New Series
This is the first post in our new series: "Why I Work at Acuitas." It will highlight some of the incredibly talented, intelligent and innovative people who work at Acuitas – and explain why they have chosen to be a
Acuitas Therapeutics Video Update
Acuitas Therapeutics is a global leader in the field of lipid nanotechnology. The team, led by President & CEO, Dr. Thomas Madden, is made up of a diverse group of highly experienced scientists and technical and administrative professionals – all
COVID-19 Vaccines and Children – an Important Conversation
Health Canada has approved the Pfizer/BioNTech COMIRNATY® mRNA vaccine for children ages five to 11. (This vaccine uses Acuitas Therapeutics’ lipid nanoparticle delivery system.) All vaccines approved for use in Canada undergo a strict testing, review and approval process. The Government